Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical & Devt. Officer

CEO and President

Chief Financial Officer

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells. In addition, the company develops Tumor-Associated Antigen and Protective Antigen Paired Discovery Platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered w...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-01	Premium	acquired	Premium	Premium	Premium	Chief Medical & Devt. Officer
2024-02-01	Premium	acquired	Premium	Premium	Premium	CEO and President
2024-02-01	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-10-03	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-06-08	Premium	acquired	Premium	Premium	Premium	-
2022-06-08	Premium	acquired	Premium	Premium	Premium	-
2022-06-08	Premium	acquired	Premium	Premium	Premium	-
2022-06-08	Premium	sold	Premium	Premium	Premium	-
2022-06-08	Premium	acquired	Premium	Premium	Premium	-
2022-06-08	Premium	sold	Premium	Premium	Premium	-

SNTI - Senti Biosciences, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for SNTI